Altamira Therapeutics Ltd. Adjustments For Decrease Increase In Trade And Other Receivables
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Decrease Increase In Trade And Other Receivables of $161.83 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables · last filed 2025-08-29
CHF
| Period end | Adjustments For Decrease Increase In Trade And Other Receivables 12 month |
|---|---|
| 2023-12-31 | 14.06K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | -103.60K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | -340.12K CHF 20-F/A · filed 2024-04-22 |
USD
| Period end | Adjustments For Decrease Increase In Trade And Other Receivables 6 month | Adjustments For Decrease Increase In Trade And Other Receivables 12 month |
|---|---|---|
| 2025-06-30 | $161.83K 6-K · filed 2025-08-29 | |
| 2024-12-31 | -$277.32K 20-F · filed 2025-04-30 | |
| 2024-06-30 | -$38.59K 6-K · filed 2025-08-29 | |
| 2023-12-31 | $15.65K 20-F · filed 2025-04-30 | |
| 2022-12-31 | -$108.48K 20-F · filed 2025-04-30 |